Boston, MA. The Massachusets General Hospital/Harvard Medical Center Department of Plastic surgery met with LifeMedix to create an alliance in the development of STATfusion. Stay tuned for more on this exciting development.
In The News
Quantico, VA. The US Marine Corps Systems Command has invited LifeMedix for a presentation and Q and A regarding STATfusion.
Ft. Detrick, MD. LifeMedix presents STATfusion at the US Army Medical Command’s Vendor Days. Much positive feedback was received.
Columbus, Ohio. The Battelle Memorial Institute’s Heath Care Division has signed on to be the development partner of STATfusion, the infusion system that has captivated home care and prehospital care end-users. The two companies are working to raise capital to fund human factors trials that will eventually be used in the FDA filings.
(Washington, DC) The US Patent and Trademark Office has allowed LifeMedix’s® second patent for the STATfusion medical infusion system.
(Beijing, China) The Chinese Patent Trademark Office has allowed LifeMedix’s® first US patent into the Chinese patent system.
Two additional patents are pending in the US and European Patent Office.
(Las Vegas, NV) The LifeMedix® team attended the EMS World Conference n Las Vegas, Nevada in September, 2013. The team presented the STATfusion medical infusion system to North America’s largest distributor of prehospital care products, along with potential strategic partners. Again, the team was met with an enthusiastic audience.
LifeMedix presents a poster at the Military Health Research Symposium in Ft. Lauderdale, Florida in August, 2013. This was an opportunity to present the STATfusion™ medical resuscitation system to the US and international military community. The device received accolades from military decision makers, regulatory officials and privately held companies.
A local health care organization makes a strategic investment in LifeMedix®.
LifeMedix® and MAGNET have agreed to collaborate on the anti-shock resuscitation device. Using Ohio Third Frontier funding, MAGNET, an Ohio Edison Technology Center, and LifeMedix® will produce the next generation Beta prototype that will be the basis for clinical testing, bench testing and regulatory approval. MAGNET’s expertise in engineering and design has a proven track record. A team of 12 engineers, FDA regulatory consultants, interns, doctors, and support staff is collaborating to produce prototype.